Impingement Syndrome Market, By Type (Primary Impingement Syndrome and Secondary Impingement Syndrome), By Impingement Site (Shoulder, Subacromial, Supraspinatus and Infraspinatus Tendon, Coracoid, Suprascapular Nerve, Subscapularis Tendon, Biceps Tendon

Impingement Syndrome Market, By Type (Primary Impingement Syndrome and Secondary Impingement Syndrome), By Impingement Site (Shoulder, Subacromial, Supraspinatus and Infraspinatus Tendon, Coracoid, Suprascapular Nerve, Subscapularis Tendon, Biceps Tendon and Others (Rotator cuff tendinitis, Glenohumeral joint impingement, etc.)), By Patient Age Group (Pediatric (children and adolescents), Adult (18-65 years) and Geriatric (65+ years)), By Treatment Type (Medication, Physical Therapy, Cortisone Injections, Surgery, Alternative Treatment and Others (Braces, Assistive devices)), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

Impingement syndrome refers to the narrowing of the subacromial space which leading to impingement of the tendons of the rotator cuff muscles. It is a condition in which the tendons of the rotator cuff of the shoulder are pinched as they pass between the top of the upper arm (humerus) and the tip of the shoulder (acromion). Impingement syndrome treatment can range from simple home treatment such as aspirin and rest to surgery, depending on how severe the impingement is. Impingement syndrome, also known as shoulder impingement, is a condition where the tendons of the rotator cuff muscles become compressed. This happens when these tendons pass through a narrow bony space in the shoulder called the subacromial space. The pressure on these tendons can cause pain and discomfort, especially when lifting the arm. Impingement syndrome can be caused by repetitive arm movements or overhead activities, which can lead to swelling and inflammation of the rotator cuff tendons. This is common in sports that require a lot of overhead movements like tennis, swimming, or weightlifting, and jobs that require repetitive arm movements. Symptoms of impingement syndrome include persistent pain in the shoulder, pain that worsens at night, and difficulty reaching up behind the back. Pain may also occur when lifting the arm overhead or while throwing a ball. Treatment for impingement syndrome often involves physical therapy, non-steroidal anti-inflammatory drugs (NSAIDs), and corticosteroid injections. In severe cases, surgery may be required.

Market Dynamics:

Increasing prevalence of musculoskeletal disorders, growing geriatric population, and rise in demand for safe & effective treatment, and increasing research and development are major factors expected to drive the growth of the global impingement syndrome market.

For instance, according to the World Health Organization (WHO), in July 2022, around 1.71 billion people across the globe worldwide have musculoskeletal conditions. Musculoskeletal conditions are the leading contributor to disability worldwide, with low back pain being the leading cause of disability in 160 countries. WHO has launched Rehabilitation 2030 Initiative to support countries to respond to existing rehabilitation needs, including people with musculoskeletal conditions, as well as the forecasted increase arising from health and demographic trends.

Key features of the study:

• This report provides in-depth analysis of the global impingement syndrome market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2023–2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global impingement syndrome market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Johnson & Johnson (DePuy Synthes), Medtronic plc., Globus Medical, Inc., Wright Medical Group N.V., Arthrex, Inc., Colfax, Össur hf., CONMED Corporation, Breg, Inc., Orthofix Medical Inc., and Bioventus LLC.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global impingement syndrome market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global impingement syndrome market

Detailed Segmentation:

• By Type:
• Primary Impingement Syndrome
• Secondary Impingement Syndrome
• By Impingement Site:
• Shoulder
• Subacromial
• Supraspinatus and Infraspinatus Tendon
• Coracoid
• Suprascapular Nerve
• Subscapularis Tendon
• Biceps Tendon
• Others (Rotator cuff tendinitis, Glenohumeral joint impingement, etc.)
• By Patient Age Group:
• Pediatric (children and adolescents)
• Adult (18-65 years)
• Geriatric (65+ years)
• By Treatment Type:
• Medication
• Physical Therapy
• Cortisone Injections
• Surgery
• Alternative Treatment
• By Region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
• Top Companies in the Global Impingement Syndrome Market:
• Johnson & Johnson (DePuy Synthes)
• Medtronic plc.
• Breg, Inc.
• CONMED Corporation
• Össur hf.
• DJO Global, Inc.
• Globus Medical, Inc.
• Wright Medical Group N.V.
• Arthrex, Inc.
• Orthofix Medical Inc.
• Bioventus LLC